Repare Therapeutics Inc (NASDAQ:RPTX) price on Friday, April 11, remained unchanged to $0.90.
A look at the stock’s price movement, the close in the last trading session was $0.90, moving within a range at $0.8972 and $0.949. The beta value (5-Year monthly) was 0.908. Turning to its 52-week performance, $4.29 and $0.89 were the 52-week high and 52-week low respectively. Overall, RPTX moved -19.64% over the past month.
Repare Therapeutics Inc’s market cap currently stands at around $38.26 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-02.
The average forecast suggests down to a -96.82% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 6.67M, representing a -87.53% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that RPTX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
4 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 3 recommend RPTX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
RPTX’s current price about -12.84% and -21.05% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 29.54, while 7-day volatility ratio is 8.56% and 6.62% in the 30-day chart. Further, Repare Therapeutics Inc (RPTX) has a beta value of 0.90, and an average true range (ATR) of 0.08. Analysts have given the company’s stock an average 52-week price target of $15, forecast between a low of $10 and high of $30. Looking at the price targets, the low is -1011.11% off current price level while to achieve the yearly target high, price needs to move -3233.33%. Nonetheless, investors will most likely welcome a -1566.67% jump to $15 which is the analysts’ median price.
If we refocus on Repare Therapeutics Inc (NASDAQ:RPTX), historical trading data shows that trading volumes averaged 0.28 over the past 10 days and 239.50K over the past 3 months. The company’s latest data on shares outstanding shows there are 42.51 million shares.
The 28.21% of Repare Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 43.02% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.0 million on 2025-03-14, giving us a short ratio of 5.22. The data shows that as of 2025-03-14 short interest in Repare Therapeutics Inc (RPTX) stood at 390.0 of shares outstanding, with shares short falling to 1.08 million registered in 2025-02-14. Current price change has pushed the stock -31.30% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RPTX stock continues to rise going into the next quarter.
